Purpose: One obstacle to providing early intervention to infants with myelomeningocele 5 (MMC) is the challenge of quantifying impaired neuromotor control of movements early in life. 6
INTRODUCTION AND PURPOSE 1
Myelomeningocele (MMC) is the most common neural tube defect in the United States, 2 affecting 1,500 to 2,000 infants born each year 1 . A primary effect of MMC is impaired sensori-3 motor function of the lower extremities, negatively influencing the ability to walk. The 4 likelihood that children with MMC will walk ranges from approximately 20% for high lumbar 5 lesions to 80% to 90% for sacral lesions, with a mean onset at 3 years or older 2, 3 . Those who do 6 walk tend to expend a high amount of energy on walking, and by late childhood many shift to 7 wheelchairs for community ambulation 2-4 . 8
Although wheelchair use to save energy for other tasks may be the optimal decision at the 9 time, this solution does not represent the optimal outcome overall. Minimizing gait energy costs 10 and maximizing gait function to allow for independent ambulation across the lifespan would be 11 an ideal outcome. Although this ideal outcome is not universally feasible, recent advances in the 12 study of neuroplasticity and neurorehabilitation suggest that better outcomes are possible. 13
Known principles of experience-dependent neuroplasticity include "use it or lose it", "use it and 14 improve it", "specificity", "repetition, intensity, time, salience and age matter" 5 . Based on these 15 principles, we propose that early intervention starting at birth, as opposed to our observations 16 here and previously of physical therapy intervention starting around 3, 6 or even 9 months of age 17 6 , is necessary to promote optimal sensori-motor development of the lower extremities and future 18 walking ability in infants with MMC. 19 Admittedly, many obstacles exist to providing aggressive early intervention from birth on 20 for infants with MMC. Multiple medical issues may limit the time available for or shift the 21 priority away from therapy interventions concerning long-term goals; parents or caregivers may 22 perceive infants with MMC as fragile; or limited therapist and family resources may make very 23 extremities less than infants with typical development (TD) 6, 15 , less movement quantity alone is 1 not sufficient to justify or guide therapeutic intervention. 2
In addition to assessing quantity of movements, another possibility is to assess how the 3 movement changes over time. Nonlinear methods of analysis assess qualitative aspects of 4 movement by directly exploring how each point in a movement trajectory influences the next and 5 how movement patterns emerge over time. By showing how the movement trajectory changes 6 across time, nonlinear methods can provide insight into the neuromotor control of the movement. 7
A specific nonlinear tool that can quantify dynamic movement patterns is Approximate Entropy 8 (ApEn). ApEn analyzes the regularity and repeatability of a signal over time. Values at zero 9 signify greatest regularity and absolute rigidity of movement patterns, while values near 2 10 represent great irregularity and very noisy movement patterns. We define these two ends of the 11 spectrum as movement patterns with low complexity, while mid-range values correspond to 12 movements that are highly complex. Thus, complexity is equated with the most well-controlled 13 and adaptive movement patterns 16, 17 . 14 Here we follow the theoretical perspective that health and optimal sensorimotor function is 15 associated with a state of maximum complexity [17] [18] [19] [20] . We test the hypothesis that spontaneous 16 lower extremity movements of infants with MMC are less complex and less organized than 17 movements of infants with TD, as indicated by lower ApEn values in infants with MMC. 18
Identifying impaired neuromotor control of lower extremity movements in infants with MMC 19 will provide support for early intervention to promote optimal sensori-motor development of the 20 lower extremities and walking ability. Further, this tool may be used to assess change in 21 underlying control due to development or specific interventions. 22
METHOD 23
The infants whose data we present here were participants in two different studies of infant 1 stepping in our laboratory, one longitudinal (Study 1) and one cross-sectional (Study 2). Each 2 study included measurement of treadmill stepping responses as well as separate recording of 3 supine spontaneous leg movements. Although the treadmill stepping protocols were different 4 between the studies, the overall length of testing and the amount of activity the infants performed 5 was similar. 6
For Study 1, infants with MMC and TD came into the laboratory at 1, 3, 6, 9 and 12 7 months of age and again at walking onset. We used a 6-camera Vicon Peak Motus real-time 8 system (Vicon Motion Systems, Centennial, CO) to collect reflective marker position data at 60 9
Hz during treadmill stepping and spontaneous movement testing 6, 21 . For Study 2, only infants 10 with MMC participated and were between the ages of 2-5 months or 7-10 months. We used 2 11 synchronized digital camcorders filming at 60Hz to record reflective marker positions during 12 treadmill stepping and spontaneous movement testing 22 . An additional 12 infants with TD were 13 invited to participate to increase our sample size and match the ages of the infants with MMC in 14 Study 2. We previously published data on the quantity of spontaneous movements for a subset of 15 the infants from Study 1 6 . Here we have expanded our sample to include additional, older 16 infants, and use a nonlinear analysis of complexity of lower extremity spontaneous movements 17 to look more closely at development of segmental control. 18
Participants 19
Overall, we included the data points for 56 infants in our analyses. Infants were 1 month of 20 age (MMC = 5, TD = 9), 3 months of age (MMC = 8, TD = 9), 6 months of age (MMC = 7, TD 21 = 6) or 9 months of age (MMC = 6, TD = 6). The data were a mix of cross-sectional and 22
longitudinal; about half of the infants were tested more than once as they reached the older age 23 groups. Specifically, two infants with MMC were tested at all 4 time points, 3 were tested 3 1 times, 3 were tested 2 times and 3 were tested once. Ten infants with TD were tested twice and 2 10 were tested once. Infants with TD were without known cognitive, sensory or motor 3 impairments. Infants with MMC had lesions (level of repair) at or caudal to L1, and were 4 excluded if they had neuromotor abnormalities other than those associated with MMC (e.g. 5
Arnold Chiari II, hydrocephalus) or if they had a gestational age at birth < 28 weeks. We 6 recruited infants through fliers and MMC clinics in hospitals in southeastern Michigan and 7 northeastern Ohio. Approval for the study was granted through the Institutional Review Board at 8 the University of Michigan and parents provided written informed consent for their infants to 9 participate in this study. Tables 1 and 2 contain participant characteristics. 10
Data Collection 11
For all spontaneous movement testing, we removed clothing and diapers and attached 12 reflective markers (8mm diameter) to the lateral surface of the greater trochanter, ventral surface 13 of the patella and ventral surface of the third metatarsal. We placed infants supine on a towel-14 covered firm surface. We held their legs extended and parallel for the initial 10 s of each trial, 15 then released their legs for the duration of data collection. A spotter stood near the infants' head 16 and maintained a hand on each shoulder to prevent the infant from rolling or scooting. Infants 17 remained in supine and moved their legs freely. During trials, parents and researchers maintained 18 conversation but did not directly interact with the infant. For Study 1, bilateral lower extremity 19 reflective marker data were collected for 2 2-minute trials and 1 1-minute trial. For Study 2, we 20 collected data from the right leg for 2 minutes and then from the left leg for 2 minutes. Infants 21
were picked up and held by their parent between trials. 22
For infants with MMC, we recorded aspects of the infant's medical history including lesion 23 level, surgeries and musculoskeletal conditions. We noted if one leg was more affected than the 1 other. If the legs were equally affected, and for infants with TD, we assigned the right leg as less 2 affected for statistical analysis. For all infants, we took anthropometric measurements including 3 body length, weight, greater trochanter to lateral malleolus length, thigh length, foot length, thigh 4 circumference and leg circumference. We assessed concurrent motor skill development level by 5 administering the motor items from the Bayley Scales of Infant Development II 7 . We recorded 6 the date of administration and whether the infant was able to perform the skill on this day. 7
Data Analysis 8
Study 1 data were collected directly in the Vicon Peak Motus software program. Study 2 9 data were transferred from the digital cameras into the software and synchronized. We then 10 digitized hip, knee and foot markers for each trial. We were able to successfully identify the 11 markers for the first 6147 frames of every trial, corresponding to the first 102.5 seconds of data 12 from each 120-s, 60 Hz recording session. Using the same number of data points for every trial is 13 important for calculating ApEn, so longer trials were shortened to provide a consistent amount of 14 data for every trial. We calculated hip segmental angles as the angle between the thigh segment 15 and the surface on which the infants rested. The angle data were then filtered with a 6 Hz 16
Butterworth filter and exported for further analyses. 17
Before we could use the nonlinear tool ApEn to assess the complexity of infants' 18 spontaneous movement data we first had to test the hip angle data for a deterministic structure 19 (mathematically defined as non-random were not random, but deterministic. 2
Next we used MATLab programs to determine the parameters necessary for ApEn 3 calculations (m = 2 and r = 0.2) and then to calculate ApEn. Note that determining parameters m 4 and r involve numerous calculations more detailed than elaborated here. For in-depth description 5 of the process, readers are directed to Stergiou et al., 2004 25 . To calculate quantity of 6 movements, we tested our data to find a threshold for movement identification that was 7 consistent with our observations of spontaneous movements during frame-by-frame video 8 analysis. We wanted to define a threshold that was much more sensitive to small movements 9 than a trained observer could see, while still consistent with observed amounts of movement. We 10 defined a movement as more than 2 degrees of hip flexion or extension in the sagittal plane in 11 167 ms, and counted the number of times this threshold was exceeded per trial. A lower number 12 for the quantity of movement value indicates fewer and/or shorter movements. 13
Statistics 14
We used a 2 (group: MMC or TD) x 2 (leg: more or less affected) x 4 (age: 1, 3, 6 or 9 15 months) linear mixed model to test for main effects and interactions. Dependent variables were 16
ApEn values in the first test and quantity of movement in the second. Group, leg and age were 17 treated as fixed effects with participant as a repeated measure (by age and leg) with a diagonal 18 structure. To look at relationships between ApEn values, motor development and factors 19 affecting motor development in infants with MMC, we tested for Pearson correlations between 20
ApEn values and lesion level (high = L1, L2, medium = L2/L3, L3, L4, or low = L4/L5, L5, S1), 21 ponderal index and age at which we observed the infant demonstrate selected items of the Bayley 22 scale (as shown in Table 3 ). We chose five items to represent major milestones across the age 23 range of our study: sits alone momentarily, sits alone 30 seconds or more, pulls to standing 1 position, walks with minimal help and walks alone, 3 steps or more. We used a two-tailed 2
Pearson correlation to determine if ApEn values were significantly correlated with the selected 3 variables in infants with MMC. For the significantly correlated milestones, we used a one-tailed 4 correlation to follow up and test whether ApEn values at 1, 3, 6 or 9 months of age were 5 significantly correlated with the age at which we observed achievement of the selected 6 milestone. We did not test for correlations in infants with TD because we only had complete 7
Bayley items for 14/30 infants with TD as we did not follow the infants with TD in Study 2 after 8 their 9-month visit to find out when they started walking independently. We used Predictive 9
Analytics Software (SPSS: An IBM Company, Chicago, IL) version 18 for statistical analysis 10 and set our alpha level of significance at 0.05. 11
RESULTS

12
ApEn Values 13
For the ApEn linear mixed model, we obtained a significant group effect (F[1,80]= 6.40, 14 p = 0.01). There was not a significant leg effect or age effect. There were no significant 15 interactions. As shown in Figure 1, Figure 2 , the significant group 22 effect was due to infants with MMC producing fewer movements than infants with TD. For the 23 significant age effect, infants produced fewer movements as they got older. Follow-up analysis 24 revealed that infants produced fewer movements at 6 and 9 months of age as compared to 1 1 month of age (p's < 0.05). 2
Correlations 3
For infants with MMC, there was a significant two-tailed negative correlation between 4
ApEn values and the age at which we observed walking alone, 3 steps or more (-0.48, p = 0.02). 5 We followed up with one-tailed correlations between the age at which we observed walking ApEn values faster. This interpretation would not be correct, however, as it overlooks the fact 6 that kicking movements change across time, infants at one month of age do not move their legs 7 like infants at nine months of age. As control develops, infants with TD are able to hold their 8 upper leg stable and move only their lower leg 29 . It follows that by moving only one segment, 9 instead of two, movements would become more regular and less complex, leading to lower ApEn 10 values. Additionally, thinking of the emergence through time of more alternating kicks and 11 eventual walking, it also fits that spontaneous leg movements would become more regular and 12 less complex as infants strengthen their patterns of alternating leg movements. Lower ApEn 13 values within age groups for infants with MMC at 3, 6 and 9 months of age, however, were 14 significantly correlated with later age of walking alone, 3 independent steps. This indicates a 15 likely interaction with lesion level, as lower ApEn values were correlated with higher lesion 16 levels. These results imply that neuromotor control of leg movements in infants with MMC is 17 fundamentally different than in infants with TD; we need to design further studies to specifically 18 investigate and understand the factors affecting developmental trajectories in infants with MMC. Currently, although they may be evaluated before discharge from the hospital following 7 birth, physical therapy intervention to address impaired neuromotor control for infants with 8 MMC is typically initiated around 3, 6 or even 9 months of age 6 (see Table 2 ). This is in contrast 9
to adults with spinal cord injury, for whom therapists, researchers and third-party payers 10 recognize the importance of aggressive early intervention to promote positive neural plasticity What happens across the first months of life, before therapy is typically initiated, is of 17 crucial importance to the development of optimal neuromotor control. Although infants with 18 MMC demonstrate the same quantity of spontaneous kicking movements before and at birth, 19 they demonstrate less movement from one month of age on as compared to infants with TD 20 6, 15, [30] [31] [32] . Lower quantity of movement relates to less organized movement through less repetitions 21 of the perception-action cycle. A lower number of movements provide diminished opportunities 22 to develop coordinated movements and neural networks that support stable leg movement 23 patterns 33 . Infants with MMC do respond adaptively to external constraints by increasing or 1 decreasing quantity of kicking 15 , demonstrating that their lower quantity of movements is 2 amenable to intervention. We propose that increasing the quantity of lower extremity movements 3 and cycles of perception-action from birth on should lead to optimal neuromotor control of the 4 legs, and that this will be reflected in higher ApEn values in infants with MMC indicating more 5 organized movements and better clinical outcomes. 6
It could be argued that lesser movement quantity alone is a sufficient, easier to obtain 7 measure of neuromotor delay in infants with MMC. Barriers to using movement quantity as a 8 clinical assessment, however, include standardizing the definition of a movement, introducing 9 observer-related variability and addressing the natural variability in infant performance. For 10 these reasons, it would be very difficult for an observer to use a stopwatch and get reliable 11 measurements of quantity of spontaneous leg movements. One could use cameras and software 12 analysis, as we do in the laboratory. While this increases the reliability of the assessment it 13 makes it much less "clinic friendly". ApEn, alternatively, can measure the regularity and 14 complexity of movement patterns as long as some minimal amount of leg movement is recorded. 15 Repeated measurements could theoretically be used to assess changes in the regularity and 16 complexity of spontaneous kicking patterns across time, independent of the fact that an infant 17 kicked more or less at a given session. We did not, however, test the inherent variability of 18 repeated measurements in this study . 19 In summary, we have shown here that ApEn reflects impaired neuromotor control and 20 less organized, less complex movements of the lower extremities of infants with MMC as 21 compared to infants with TD starting at one month of age. Our study begins to demonstrate the 22 feasibility of ApEn as a valuable tool for identifying and quantifying impaired neuromotor 23 control in infants with MMC. ApEn assessment adds unique information to current clinical 1 assessments and supports the need for therapeutic intervention early in life. 2 3 STUDY LIMITATIONS 4 5 The major limitation of our study is that it is not a longitudinal design. Additionally, we 6 report only lesion level of surgical repair, which is not as meaningful for behavior as a functional 7
neurological level. We only tested infants once at each time point, and infant behavior is 8 inherently variable. It would be ideal to test infants twice at each age and follow them from birth 9 through independent walking, and we plan to pursue such a study. Such a design would allow us 10 to test the inherent variability of ApEn measurements as well as rigorously test the relationship 11 between ApEn, factors affecting motor development and outcomes in infants with MMC. This 12 study, however, provides necessary background information on the feasibility and usefulness of 13
ApEn as an outcome measure before recruiting infants and their families for a study design that 14 would be much more demanding of their time. We also appreciate the need for software 15 development to allow clinicians to collect and analyze data without using research laboratory 16 resources. 17 
